摘要
目的观察莫沙必利与坦洛新联合治疗糖尿病神经源性膀胱的疗效。方法选取40例2型糖尿病神经源性膀胱患者,给予莫沙必利与坦洛新联合治疗4周,比较治疗前后B超膀胱残尿量的变化。结果治疗后B超测定的残尿量(52±6)ml较治疗前的(190±21)ml明显减少,差异有统计学意义(t=6.677,P<0.05))。结论莫沙必利、坦洛新联合治疗糖尿病神经源性膀胱,可以明显改善尿潴留,有较好的临床疗效。
Objective To observe the efficacy of Mosapride and Tamsuloin in treating diabetic neurogenic bladder.Methods 40 pations with type2 diabetes and diabetic neurogenic bladder were treated with Mosapride and Tamsuloin for 4 weeks and The postvoiding residue of bladder measured by ultragonogram were compared befor and after therapy.Results The postvoiding residue of bladder after therapy（52±6）ml were significantly decreased than those before therapy（190±21）ml（t=6.677,P〈0.05）.Conclusion Mosapride and Tamsuloin can significantly improve the improve the postvoiding residue of bladder in pations with diabetic neurogenic bladder.
出处
《临床合理用药杂志》
2013年第3期53-54,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
莫沙必利
坦洛新
糖尿病
治疗结果
Mosapride
Tamsuloin
Diabetes mellitus
Treatment outcome
